Cerner Corporation

Shares of Cerner Corporation (NASDAQ: CERN) were trading lower by more than 1 percent on Monday after the company's CEO disclosed in a letter to clients, shareholders and colleagues he has been diagnosed with a soft tissue cancer. Cerner's CEO, Neal Patterson, said in a letter he was...

Citi reiterated its Buy rating on Cerner Corporation (NASDAQ: CERN). At the same time, Citi increased its price target on the company's stock from $117 to $152. In a research report published today, Citi cited increasing healthcare IT spending as the reason for its decision. In the report, Citi...

Citigroup has raised the price target on Cerner Corporation (NASDAQ: CERN) from $117 to $152 and maintains its Buy rating.

Deutsche Bank has raised the price target on Cerner (NASDAQ: CERN) from $107 to $116 and maintains its Hold rating.

JP Morgan has raised the price target on Cerner (NASDAQ: CERN) from $115 to $120 and maintains its Overweight rating.

BMC Drops Coverage of Cerner Corporation (CERN) BMC is dropping its coverage of Cerner Corporation (NASDAQ: CERN). Shares of CERN closed Monday at $106.01, up 2.82% from Friday's close.

JP Morgan has published a research report on Cerner Corporation (NASDAQ: CERN) after the company reported strong 4Q results. In the report, JP Morgan writes "4Q bookings of $626M were well ahead of our $510M forecast and company guidance of $490-530M. The number of contracts signed in excess of $5M...

JP Morgan has published a research report on Cerner Corporation (NASDAQ: CERN) after the company reported strong 4Q results. In the report, JP Morgan writes "4Q bookings of $626M were well ahead of our $510M forecast and company guidance of $490-530M. The number of contracts signed in excess of $5M...

JP Morgan has raised the price target on Cerner Corporation (NASDAQ: CERN) from $110 to $116 and maintains its Overweight rating.

Morgan Keegan has raised the price target on Cerner Corporation (NASDAQ: CERN) from $106 to $109 and maintains its Outperform rating.

Piper Jaffray is raising its target on Cerner Corporation (NASDAQ: CERN) to $108 from $92.

Cerner Corporation (NASDAQ: CERN) is expected to gain market share, and its win-rate against Epic appears to be improving. PiperJaffray reiterates its "overweight" rating and price target of $98. Software sales are 90%+ margins, support is 76%, implementation revenue and managed services...